Your browser is no longer supported. Please, upgrade your browser.
Settings
VKTX Viking Therapeutics, Inc. daily Stock Chart
VKTX [NASD]
Viking Therapeutics, Inc.
Index- P/E- EPS (ttm)-0.45 Insider Own9.20% Shs Outstand74.76M Perf Week-5.60%
Market Cap870.21M Forward P/E- EPS next Y-0.49 Insider Trans-2.67% Shs Float59.47M Perf Month-19.39%
Income-20.90M PEG- EPS next Q-0.12 Inst Own54.50% Short Float37.36% Perf Quarter15.48%
Sales- P/S- EPS this Y12.50% Inst Trans15.64% Short Ratio4.87 Perf Half Y135.15%
Book/sh4.93 P/B2.36 EPS next Y-6.70% ROA-15.10% Target Price32.33 Perf Year321.74%
Cash/sh4.07 P/C2.86 EPS next 5Y40.00% ROE-15.80% 52W Range2.53 - 24.00 Perf YTD186.70%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-51.50% Beta2.80
Dividend %- Quick Ratio64.60 Sales past 5Y- Gross Margin- 52W Low359.90% ATR1.30
Employees4 Current Ratio64.60 Sales Q/Q- Oper. Margin- RSI (14)36.38 Volatility12.01% 10.86%
OptionableYes Debt/Eq0.00 EPS Q/Q51.50% Profit Margin- Rel Volume0.58 Prev Close11.40
ShortableYes LT Debt/Eq0.00 EarningsNov 07 AMC Payout- Avg Volume4.56M Price11.64
Recom1.90 SMA20-11.76% SMA50-18.82% SMA20024.07% Volume2,629,176 Change2.11%
Sep-18-18Reiterated Raymond James Outperform $15 → $43
Sep-18-18Reiterated Maxim Group Buy $14 → $28
Sep-18-18Reiterated H.C. Wainwright Buy $15 → $28
Jul-20-18Initiated SunTrust Buy $14
Jun-28-18Initiated Raymond James Outperform
Jun-01-18Reiterated Laidlaw Buy $10 → $15
May-31-18Reiterated Maxim Group Buy $8 → $14
Mar-26-18Resumed H.C. Wainwright Buy $11
Nov-28-17Reiterated Maxim Group Buy $5 → $8
Nov-21-17Initiated ROTH Capital Buy
Nov-10-17Resumed H.C. Wainwright Buy $7
Jul-17-17Reiterated H.C. Wainwright Buy $5 → $7
Aug-11-16Reiterated Laidlaw Buy $20 → $10
May-24-16Initiated Maxim Group Buy $5
Apr-07-16Initiated H.C. Wainwright Buy $6
Nov-15-18 09:27PM  Edited Transcript of VKTX earnings conference call or presentation 7-Nov-18 9:30pm GMT Thomson Reuters StreetEvents
Nov-14-18 09:30AM  4 Healthcare Stocks To Watch On Wednesday ACCESSWIRE
08:31AM  Better NASH Stock: Madrigal Pharmaceuticals, Inc. vs. Viking Therapeutics, Inc. Motley Fool
06:50AM  Todays Research Reports on Stocks to Watch: Viking Therapeutics and EyeGate Pharmaceuticals ACCESSWIRE
Nov-13-18 04:36PM  Stocks on the move: higher transportation and raw material cost clash with Home Depot's profitability Yahoo Finance Video
11:54AM  Viking Therapeutics Shows How Quickly This Market Can Turn TheStreet.com
11:00AM  VKTX: Phase 2 Data for VK2809 Presented at AASLD Zacks Small Cap Research
10:45AM  Why Viking Therapeutics Shares Are Finding Renewed Buying Interest Benzinga
09:15AM  4 Stocks To Watch As Healthcare Technology Industry Is Expecting Rapid Growth Through 2025 ACCESSWIRE
08:00AM  Why Viking Therapeutics Stock Is Bolting Higher Today Motley Fool
Nov-12-18 06:55PM  Viking Therapeutics Presents Results from Phase 2 Study of VK2809 in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Elevated LDL-Cholesterol in Oral Late-Breaker Presentation at The Liver Meeting® 2018 PR Newswire
Nov-08-18 12:36PM  Ligand Pharmaceuticals Inc (LGND) Q3 2018 Earnings Conference Call Transcript Motley Fool -6.41%
Nov-07-18 04:05PM  Viking Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update PR Newswire
09:15AM  Why Viking Therapeutics Stock Sank in October Motley Fool
Oct-31-18 07:35AM  Viking Therapeutics to Report Financial Results for Third Quarter 2018 on November 7, 2018 PR Newswire
Oct-27-18 07:00AM  Where Will Gilead Sciences, Inc. Be in 5 Years? Motley Fool
Oct-25-18 04:18PM  3 Top Stocks Under $20 Motley Fool +7.26%
Oct-24-18 09:25AM  Detailed Research: Economic Perspectives on Paychex, Coty, Bright Scholar Education, LendingClub, Energy Fuels, and Viking Therapeutics What Drives Growth in Today's Competitive Landscape GlobeNewswire -9.56%
Oct-23-18 10:54AM  CAT Stock Gets Thrown Into the Dumpster TheStreet.com
Oct-14-18 06:32AM  3 Top Small-Cap Stocks to Buy in October Motley Fool
Oct-11-18 02:21PM  Here's Why Viking Therapeutics Skyrocketed 33% in September Motley Fool
Oct-08-18 07:02AM  Viking Therapeutics Announces Data from In Vivo Study of VK2809 Presented at Oral Plenary Session of the 88th Annual Meeting of American Thyroid Association (ATA) PR Newswire -5.39%
Oct-05-18 11:00AM  Liver Cancers Rising - Stocks to Watch ACCESSWIRE
Oct-04-18 08:51AM  3 Top Small-Cap Stocks to Buy Right Now Motley Fool
07:02AM  Viking Therapeutics Announces VK2809 Phase 2 Study Results Selected for Oral Late-Breaker Presentation at The Liver Meeting® 2018 PR Newswire
Oct-03-18 10:30AM  VKTX: Presentation of Full Data Set for VK5211 Phase 2 Trial Zacks Small Cap Research
Oct-02-18 06:02AM  3 Reasons Why Buying Viking Therapeutics on the Dip Could Pay Off Big Motley Fool -5.98%
Oct-01-18 08:29AM  Viking Therapeutics stock jumps 4.8% premarket on news of positive trial results MarketWatch -6.95%
08:00AM  Today's Research Reports on Trending Tickers: Viking Therapeutics and Amarin ACCESSWIRE
07:02AM  Viking Therapeutics Presents Results from Phase 2 Study of VK5211 in Patients Recovering from Hip Fracture in Plenary Oral Presentation at ASBMR 2018 Annual Meeting PR Newswire
Sep-30-18 10:14AM  The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Results And IPOs Benzinga
Sep-27-18 06:31AM  The Greatest Healthcare Stocks of the 21st Century -- and Some That Probably Will Be Motley Fool
Sep-26-18 03:21PM  5 Biotech Stocks to Play the Sectors Next Big Trend: NASH InvestorPlace
07:35AM  Viking Therapeutics to Participate in Upcoming Investor Conferences PR Newswire
Sep-25-18 10:00AM  Forget Tilray, These 2 Biotech Stocks Have Far More Upside Motley Fool
Sep-24-18 01:00PM  VKTX: Positive Results for Phase 2 Study of VK2809 in NAFLD Zacks Small Cap Research +5.99%
Sep-22-18 07:17AM  3 Biotech Stocks That Soared This Week: Are They Buys? Motley Fool
Sep-20-18 08:06PM  Viking Therapeutics Announces Pricing of $175.8 Million Public Offering of Common Stock PR Newswire
09:02AM  The Daily Biotech Pulse: Adverum Snags Fast Track Designation, Crispr To Offer Shares, Elanco Animal Health To Debut Benzinga
08:48AM  Is Viking Therapeutics the Best NASH Stock to Buy Now? Motley Fool
Sep-19-18 04:21PM  Viking Therapeutics Announces Proposed Public Offering of Common Stock PR Newswire
11:01AM  Biotech Stock Roundup: CELG, REGN Present Data, VKTX Soars on Drug's Success Zacks
10:13AM  Viking Therapeutics Liver Candidate Passes Test, Shares Soar Zacks
08:47AM  The Daily Biotech Pulse: Johnson & Johnson's Generic Unit Files NDA For Urinary Tract Cancer Drug, G1 Therapeutics Prices Offering Benzinga
08:00AM  Todays Research Reports on Stocks to Watch: Viking Therapeutics and Realm Therapeutics ACCESSWIRE
07:06AM  Viking Therapeutics stock rose 87% on results for its liver disease drug and the company has more in store this fall MarketWatch
Sep-18-18 05:04PM  What Happened in the Stock Market Today Motley Fool +87.30%
03:00PM  Viking Therapeutics and Madrigal Pharmaceuticals Are Racing to the Finish Line in NASH Motley Fool
11:55AM  Stocks Ignore Tariff News, And This Might Explain Why Investor's Business Daily
11:26AM  Viking Therapeutics Stock Skyrockets on Promising Fatty Liver Treatment Results InvestorPlace
10:00AM  Why Viking Therapeutics Stock Is Soaring Today Motley Fool
08:14AM  UPDATE: Viking Therapeutics stock rockets 140% after positive trial of non-alcoholic fatty liver treatment MarketWatch
07:21AM  Viking Therapeutics liver drug succeeds in mid-stage study Reuters
07:05AM  Viking Therapeutics Announces Positive Top-Line Results from Phase 2 Study of VK2809 in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Elevated LDL-Cholesterol PR Newswire
07:05AM  Viking Almost Triples After Fatty Liver Drug Meets Study Goals Bloomberg
Sep-11-18 06:30AM  3 Surging Biotech Stocks -- Can They Keep Climbing? Motley Fool
Sep-10-18 02:17PM  Six Biotechnology Names on My Watch List TheStreet.com
Sep-04-18 06:00AM  Why Viking Therapeutics Stock Gained 27% in August Motley Fool
Aug-30-18 01:38PM  A Lesson to Learn From Thursday's Market Action TheStreet.com +6.46%
Aug-29-18 06:00AM  Can Viking Therapeutics Stock Sail Even Higher? Motley Fool +5.23%
Aug-28-18 07:30AM  Viking Therapeutics to Participate in Upcoming Investor Conferences PR Newswire
Aug-24-18 08:00AM  Today's Research Reports on Stocks to Watch: Obalon Therapeutics and Viking Therapeutics ACCESSWIRE
Aug-19-18 09:02AM  Is Viking Therapeutics, Inc. a Buy? Motley Fool
Aug-15-18 04:43PM  3 Growth Stocks for in-the-Know Investors Motley Fool
Aug-13-18 09:45AM  VKTX: Data from P2 Trial of VK2809 in 4Q18 Zacks Small Cap Research
Aug-09-18 04:05PM  Viking Therapeutics Reports Second Quarter 2018 Financial Results and Provides Corporate Update PR Newswire
02:30PM  Viking Therapeutics, Inc. to Host Earnings Call ACCESSWIRE
Aug-02-18 07:30AM  Viking Therapeutics to Report Financial Results for Second Quarter 2018 on August 9, 2018 PR Newswire
Jul-30-18 06:00AM  Analyst-Turned-CEO Says His Biotech Stock Is Cheap, Even After a 900% Rally Bloomberg -6.99%
Jul-25-18 07:45AM  Complimentary Technical Snapshots on Viking Therapeutics and Three More Biotech Stocks ACCESSWIRE
Jul-21-18 08:25AM  Should Biotech Investors Fear Dilution? Motley Fool
Jul-17-18 07:05AM  Viking Therapeutics Announces VK5211 Phase 2 Study Results Selected for Plenary Oral Presentation at ASBMR 2018 Annual Meeting PR Newswire -8.38%
Jul-14-18 07:16AM  3 Biotech Stocks With Big News Coming in NASH Motley Fool
Jul-13-18 07:31AM  3 Top Biotech Stocks to Buy Right Now Motley Fool
Jul-08-18 09:30AM  3 Top Biotech Stocks to Buy for the 2nd Half of 2018 Motley Fool
Jun-26-18 11:27AM  Viking Therapeutics, Buy the Dip? Motley Fool
07:06AM  This Is the Most Undervalued NASH Drug Stock, and Wall Street Is Ignoring It Motley Fool
Jun-20-18 06:01AM  3 Small-Cap Biotech Stocks to Keep on Your Radar Motley Fool
Jun-15-18 02:31PM  Cash for NASH: 2 Top Biotech Takeover Targets and 3 Potential Buyers Motley Fool +10.49%
09:40AM  3 Growth Stocks at Deep-Value Prices Motley Fool
08:10AM  Investor Expectations to Drive Momentum within NovoCure, Canada Goose, Telephone and Data, FMC, MobileIron, and Viking Therapeutics Discovering Underlying Factors of Influence GlobeNewswire
Jun-14-18 10:30AM  Are These Red-Hot NASH Stocks Still a Buy? Motley Fool
Jun-13-18 04:03PM  Here's Why Viking Therapeutics Rose as Much as 14.9% Today Motley Fool +9.09%
Jun-12-18 02:15PM  VKTX: Final Patient Enrolled in P2 Trial of VK2809; Raises Gross Proceeds of $77.6M in Public Offering Zacks Small Cap Research
07:05AM  Viking Therapeutics Announces Closing of Public Offering of Common Stock PR Newswire
Jun-11-18 10:31AM  2 Cheap Growth Stocks to Buy Right Now Motley Fool +8.59%
Jun-08-18 09:18AM  Now's the Time to Buy These 3 Stocks Motley Fool
Jun-07-18 08:30AM  Viking Therapeutics Announces Pricing of $67.5 Million Public Offering of Common Stock PR Newswire +6.39%
Jun-06-18 04:01PM  Viking Therapeutics Announces Proposed Public Offering of Common Stock PR Newswire
08:15AM  Viking Therapeutics Recent VK2809 Update, Analyst Review and Target ACCESSWIRE
Jun-05-18 07:40AM  Complimentary Technical Snapshots on Viking Therapeutics and Three More Biotech Stocks ACCESSWIRE
07:01AM  Viking Therapeutics Completes Enrollment in Phase 2 Study of VK2809 in Patients with Hypercholesterolemia and Non-Alcoholic Fatty Liver Disease PR Newswire
Jun-02-18 04:10PM  Maxim Explains Viking Therapeutics' Sympathy Move With Madrigal Benzinga
07:17AM  3 Biotech Stocks That Soared This Week: Are They Buys? Motley Fool
Jun-01-18 10:00AM  VKTX: Positive Data from Madrigal is Positive for Viking; Raising Valuation to $16 Zacks Small Cap Research
09:07AM  Benzinga Pro's 5 Stocks To Watch Today Benzinga
08:10AM  Todays Research Reports on Stocks to Watch: Madrigal Pharmaceuticals and Viking Therapeutics ACCESSWIRE
05:10AM  Viking Therapeutics Breaks Out to Key Resistance Levels Investopedia
May-31-18 04:02PM  Madrigal Pharma Shares Double After Successful Phase II Results For Fatty Liver Drug Forbes +101.01%
12:27PM  Why Viking Therapeutics Stock Is On Fire Today Motley Fool
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. Its lead clinical program, VK5211, is an orally available, non-steroidal selective androgen receptor modulator in Phase II development for the treatment of patients recovering from non-elective hip fracture surgery; in Phase I clinical trials for improving lean body mass; and in pre-clinical trial for improving bone mineral density, bone mineral content, bone strength, and other measures. The company is also developing VK2809, an orally available, tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta, which is in a Phase II clinical trial for the treatment of patients with hypercholesterolemia and fatty liver disease; and in a Phase I clinical trial to treat patients who suffer from glycogen storage disease type Ia. In addition, it is developing VK0214 for X-linked adrenoleukodystrophy, which is in pre-clinical stage. Viking Therapeutics, Inc. was founded in 2012 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LIGAND PHARMACEUTICALS INC10% OwnerSep 25Sale19.15262,8815,034,2506,038,083Sep 27 09:25 PM
SINGLETON J MATTHEWDirectorMay 31Buy9.829,50093,2619,500May 31 07:04 PM
MORNEAU MICHAELVP, Finance and AdministrationMay 31Sale9.2521,551199,34794,035May 31 07:03 PM
Rowland Charles A JrDirectorMay 29Buy5.1630,000154,80030,000May 31 07:02 PM
Webster Stephen WDirectorMay 29Buy5.218,00041,7128,000May 31 06:59 PM
MACARTNEY LAWSONDirectorMay 29Buy5.2247,965250,32947,965May 31 06:57 PM